BRIDGEWAY CAPITAL MANAGEMENT, LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2018$124,000
-75.7%
109,800
-40.6%
0.00%
-60.0%
Q3 2018$510,000
+78.9%
184,800
+131.6%
0.01%
+66.7%
Q2 2018$285,000
+16.3%
79,8000.0%0.00%0.0%
Q1 2018$245,000
-51.3%
79,8000.0%0.00%
-40.0%
Q4 2017$503,000
-7.9%
79,8000.0%0.01%
-16.7%
Q3 2017$546,000
-4.0%
79,8000.0%0.01%
-14.3%
Q2 2017$569,000
-60.0%
79,800
-48.4%
0.01%
-58.8%
Q1 2017$1,423,000
+25.7%
154,800
-44.9%
0.02%
+13.3%
Q4 2016$1,132,000
+5.2%
280,9000.0%0.02%
-6.2%
Q3 2016$1,076,000
-30.8%
280,900
-22.3%
0.02%
-33.3%
Q2 2016$1,555,000
+29.0%
361,717
+1324.1%
0.02%0.0%
Q2 2015$1,205,000
-34.2%
25,400
-49.2%
0.02%
-36.8%
Q1 2015$1,832,000
-7.8%
50,0000.0%0.04%
-15.6%
Q4 2014$1,986,000
+99.0%
50,0000.0%0.04%
+80.0%
Q3 2014$998,000
+47.9%
50,0000.0%0.02%
+38.9%
Q2 2014$675,00050,0000.02%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders